Table 1.
Patient demographics, characteristics, baseline pain levels, and analgesics (n=24)
| Variable | Value(s) |
|---|---|
| Age, years | |
| Mean | 53.33 |
| Range | 38-80 |
| SD | 10.11 |
| Sex, n (%) | |
| Male | 12 (50) |
| Female | 12 (50) |
| Ethnicity, n (%) | |
| Sinhalese | 17 (70.83) |
| Muslim | 2 (8.33) |
| Tamil | 2 (8.33) |
| Burgher | 1 (4.16) |
| Level of baseline pain on day 1/arm A (in accordance with VAS pain level categories,[31] n (%) | |
| Mild (1-3/10) | 3 (12.5) |
| Moderate (4-6/10) | 8 (33.33) |
| Severe (7-10/10) | 13 (54.16) |
| Analgesics (levels of analgesia provided according to the WHO analgesic ladder[32] | |
| WHO analgesic ladder 1 | 3 (16.66) |
| WHO analgesic ladder 2 | 5 (20.83) |
| WHO analgesic ladder 3 | 8 (33.33) |
| Additional use of adjuvants | 8 (33.33) |
| Adjuvants (dexamethasone) alone | 8 (33.33) |
| Patients who usually enjoy listening to music, n (%) | 20 (83.33) |
| System involving primary malignancy, n (%) | |
| Hematological | 1 (4.17) |
| Respiratory tract | 3 (12.5) |
| Gastrointestinal | 11 (45.83) |
| Gynecological | 3 (12.5) |
| Endocrine | 3 (12.5) |
| Male reproductive | 1 (4.17) |
| Musculoskeletal | 2 (8.33) |
| Metastatic status | |
| Metastatic | 8 (33.33) |
| Unknown/not-documented | 16 (66.66) |
| Patients who thought analgesics were harmful overall, n (%) | 4 (16.66) |
| Patients who disliked administration of analgesics, n (%) | 1 (4.17) |
WHO: World Health Organization, VAS: Visual analog scale, SD: Standard deviation